H. Yilmaz Et Al. , "Methylenetetrahydrofolate reductase C677T mutation has an important effect on hyperhomocysteinemia and left ventricul hypertrophy in patients with type II diabetes mellitus," 13th European Meeting on Hypertension , vol.21, Milan, Italy, 2003
Yilmaz, H. Et Al. 2003. Methylenetetrahydrofolate reductase C677T mutation has an important effect on hyperhomocysteinemia and left ventricul hypertrophy in patients with type II diabetes mellitus. 13th European Meeting on Hypertension , (Milan, Italy).
Yilmaz, H., Agachan, B., Ergen, H., Karaali, Z., & Isbir, T., (2003). Methylenetetrahydrofolate reductase C677T mutation has an important effect on hyperhomocysteinemia and left ventricul hypertrophy in patients with type II diabetes mellitus . 13th European Meeting on Hypertension, Milan, Italy
Yilmaz, Hülya Et Al. "Methylenetetrahydrofolate reductase C677T mutation has an important effect on hyperhomocysteinemia and left ventricul hypertrophy in patients with type II diabetes mellitus," 13th European Meeting on Hypertension, Milan, Italy, 2003
Yilmaz, Hülya Y. Et Al. "Methylenetetrahydrofolate reductase C677T mutation has an important effect on hyperhomocysteinemia and left ventricul hypertrophy in patients with type II diabetes mellitus." 13th European Meeting on Hypertension , Milan, Italy, 2003
Yilmaz, H. Et Al. (2003) . "Methylenetetrahydrofolate reductase C677T mutation has an important effect on hyperhomocysteinemia and left ventricul hypertrophy in patients with type II diabetes mellitus." 13th European Meeting on Hypertension , Milan, Italy.
@conferencepaper{conferencepaper, author={Hülya YILMAZ AYDOĞAN Et Al. }, title={Methylenetetrahydrofolate reductase C677T mutation has an important effect on hyperhomocysteinemia and left ventricul hypertrophy in patients with type II diabetes mellitus}, congress name={13th European Meeting on Hypertension}, city={Milan}, country={Italy}, year={2003}}